Data & Congress Presentations
Emergex’s Next Generation Vaccines: Naturally processed & presented MHC class I ligandome libraries for the development of T cell priming immune set-point vaccines against infectious pathogens
Delaware valley mass spectrometry discussion group monthly meeting
Novel gene identification in the influenza virus infection model using multi-omics approach, reveals potential CD8+ T-cell adaptive vaccine candidates
71st Annual American Society for Mass Spectrometry (ASMS) conference
A novel immunoproteomic approach to MHC class I-restricted peptide discovery for influenza CD8+ T cell adaptive vaccine development
71st Annual American Society for Mass Spectrometry (ASMS) conference
Rapid Emergex Antigen Deployment Initiative (READI): a synthetic T cell vaccine technology platform pairing a gold nanoparticle delivery system with select targets from a ligandome of prescreened pathogen derived, naturally processed & presented MHC-I peptides to provide rapid response solutions to combat and broadly protect against biothreat pathogens
2022 DTRA CBD S&T conference
New approach: MHC class I peptide libraries for the treatment of viral and bacterial infectious diseases by innovative multi-epitope T cell adaptive vaccines
2022 DTRA CBD S&T conference
Characterization of a T cell adaptive vaccine platform to prime a broad and durable immunogenic response against Dengue virus infection
ISAC: Cyto 2023
